Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction- The TRANSFER-AMI Trial

NCT00164190 is registered in ClinicalTrials.gov with Canadian Heart Research Centre as lead sponsor.

NCT NCT00164190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00164190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction- The TRANSFER-AMI Trial
Lead sponsor
Canadian Heart Research Centre
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2004
Completion date
January 31, 2009
Enrollment
1,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction